ClinicalTrials.gg
CompletedNCT03646032SAAFEUpdated Dec 16, 2019

Sexually Active Adolescent Focused Education

An interventional study of SAAFE and Control in Health Risk Behaviors, sponsored by Benten Technologies, Inc.. Completed at 2 sites in United States. Open to participants aged 15 Years to 21 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-12-16.

Sponsored by Benten Technologies, Inc. · Not applicable, Interventional, and Prevention

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
178
Allocation
Randomized
Ages
15 Years to 21 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 25 studies in Health Risk Behaviors with a site in United States — 6 open to participants now, 9 under way, none of them phase 3. Health Risk Behaviors · United States.

Enrollment
9th of 24
178 · median 138
Started
2019
the only one that year
No phase
23 of 25
5 open now
Registered
4th of 25
by date
Lead sponsor
1 of 25
Benten Technologies, Inc.

Among the 25 studies in Health Risk Behaviors with a site in United States, this one is the 9th largest by enrollment of the 24 interventional ones that give a count, is the only one that started in 2019, is one of 23 with no phase, and was the 4th registered.

Health Risk Behaviors

60 studies on the registry are indexed under Health Risk Behaviors; 16 are open to participants now.

Browse Health Risk Behaviors studies →

Open to participants now

6 of the 25 studies in Health Risk Behaviors with a site in United States are open now. Recruiting first, the newest first:

1 more — sign in →

All 6 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 9 Health Risk Behaviors studies recruiting now, 5 set no upper age limit and 2 stop at 75 or younger; 1 takes children under 18; 4 take healthy volunteers.

This study: 15 Years to 21 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 25 studies in Health Risk Behaviors with a site in United States, or all of them as a file.
02

Study summary

SAAFE will be pilot tested in 2 geographically distinct areas (Washington, DC and Deep South) with 100 participants from each site to 1) primarily assess the efficacy of improved self-efficacy, knowledge about HIV/STIs and perception of sexual risks by AAAs, and (2) secondarily detect intention to be tested for STIs and to change sexual risk behavior (i.e., use a condom).

Read the detailed description

A total of 200 African American adolescents (AAA) males and females will be recruited from Washington, DC (n=100) and Birmingham, Alabama (n=100). At both data collection sites, participants will be randomly assigned to one of two groups during the pilot. The two groups are:

  1. Intervention group (n=100) - will consist of 50 AAA males / 50 AAA females randomly selected participants who will receive a download of the SAAFE game and play for at least 30 minutes and as long as an hour, if desired.
  2. Control group (n=100) - will consist of 50 AAA males / 50 AAA females randomly selected participants. This group will receive dating sim game (called Choices). They will also receive pamphlets that provide information on the testing location and care if they have HIV/STI.
03

Conditions studied

  • Health Risk Behaviors

Keywords

  • Mobile dating simulation game
  • Sexual education
  • HIV
  • STI
  • Consent
04

Who can participate

Ages eligible
15 Years to 21 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • African American female or male
  • Between 15-21 years of age

Exclusion criteria

Exclusion Criteria:

  • Pregnant women
  • The first 6 weeks post-partum
  • Adolescents younger than 15
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
178 participants (actual)

Study arms

  • Experimental
    Intervention group

    Intervention group (n=200) - will consist of 100 AAA males / 100 AAA females randomly selected participants who will receive a download of the SAAFE game and play for at least 30 minutes and as long as an hour, if desired.

    Behavioral: SAAFE

  • Active comparator
    Control group

    Control group (n=200) - will consist of 100 AAA males / 100 AAA females randomly selected participants. This group will receive the standard of care by launching a mobile app that will play a dating sim game (called Choices). They will also receive pamphlets that provide information on the testing location and care if they have HIV/STI.

    Behavioral: Control

Interventions

  • BehavioralSAAFE

    After completing the pre-game assessment, participants will be asked to play the SAAFE game for at least 30 minutes and up to 1 hour . At the conclusion of the game, participants will be provided with a post-game assessment about their perception of risk, knowledge of specific protective behaviors, and whether they plan to change behaviors.

  • BehavioralControl

    This group will receive dating sim game (called Choices). They will also receive pamphlets that provide information on the testing location and care if they have HIV/STI.

06

What researchers measure

Primary outcomes

  1. Knowledge about HIV/STIs

    During the pilot, adolescents will be asked if they would like to download the game to play on their own mobile device and complete a pre- and post-game assessment designed to measure their knowledge on HIV/STIs by assessing the level of knowledge around risky sexual activity.

    Time frame: 1 month

Secondary outcomes

  1. Perception of sexual risks

    During the pilot, adolescents will be asked if they would like to download the game to play on their own mobile device and complete a pre- and post-game assessment designed to measure their perceived risk

    Time frame: 1 month

  2. Intention to be tested for STIs

    We will ask participants on a scale of 1-5 their intent to get tested for HIV and most common STI's.

    Time frame: 1 month

  3. Intention to use a condom

    We will ask participants on a scale of 1-5, their intent to use a condom.

    Time frame: 1 month

  4. Consent

    We will ask participants on a 4-point Likert scale (strongly agree to strongly disagree)

    Time frame: 1 month

  5. System Usability and Acceptability Metrics

    We will ask participants to answer the questions based on their current impressions on the game.

    Time frame: 1 month

07

Study locations

2 sites
  • The University of Alabama at Birmingham
    Birmingham, Alabama 35294, United States
  • Medstar Washington Hospital Center
    Washington, District of Columbia 20010, United States
08

References and documents

Individual participant data

Plan to share: Yes

Supporting information: Study protocol, Informed consent form, Clinical study report, Analytic code

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2019 to primary completion in Jul 2019, 2 months.

Of 37 interventional studies with no phase under Health Risk Behaviors, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 32. This study's 2 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 21, 2018
First posted
Aug 24, 2018
StartActual
May 8, 2019
Primary completionActual
Jul 15, 2019
CompletionActual
Jul 15, 2019
Last update
Dec 16, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 16, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03646032
Lead sponsor
Benten Technologies, Inc.
Responsible party
Tony Ma (President, Benten Technologies, Inc.) — Principal investigator
First posted
Aug 24, 2018
Start date
May 8, 2019
Primary completion
Jul 15, 2019
Completion
Jul 15, 2019
Last update
Dec 16, 2019

Study contacts

Tony Ma, MS
principal investigator · Benten Technologies, Inc.

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion